is semaglutide fda approved for obesity Tirzepatide vs Semaglutide: What You Need to Know Weight Loss Medications-Compare Ozempic, Wegovy,

The STEP trials assessed the efficacy and safety of semaglutide 2.4 mg in individuals with overweight (BMI 27.0 kg/m with at least one weight-related comorbidity) or obesity (BMI 30.0 kg/m), both with and without T2D or prediabetes

doi:10.1016/S2213-8587(24)00163-3 Cai TT, Li HQ, Jiang LL, et al

Zheng, Y., Lai, L., Liu, W., Jiang, H

In the Zepbound trials, nausea occurred in roughly 25-29% of patients, diarrhea in about 19-23%, vomiting in about 8-13%, and constipation in about 11-17% across doses, along with abdominal pain

But the drugs high cost has prompted several commercial insurance companies to drop coverage

Before ending the discussion, its a good idea to make a plan to check in on your progress with your doctor